Cargando…

Effectiveness of messenger RNA vaccines against infection with SARS-CoV-2 during the periods of Delta and Omicron variant predominance in Japan: the Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study

OBJECTIVES: We aimed to evaluate COVID-19 messenger RNA vaccine effectiveness during the Delta- and Omicron-predominant periods in Japan. METHODS: We conducted a population-based cohort study among individuals aged 16–64 years during two periods: the Delta-predominant period (July 1–December 31, 202...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mimura, Wataru, Ishiguro, Chieko, Maeda, Megumi, Murata, Fumiko, Fukuda, Haruhisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547653/ https://www.ncbi.nlm.nih.gov/pubmed/36220547 http://dx.doi.org/10.1016/j.ijid.2022.10.001

Ejemplares similares

Effectiveness of a Third Dose of COVID-19 mRNA Vaccine During the Omicron BA.1- and BA.2-Predominant Periods in Japan: The VENUS Study
por: Mimura, Wataru, et al.
Publicado: (2022)

Bivalent Vaccine Effectiveness Among Adults Aged ≥65 Years During the BA.5-Predominant Period in Japan: The VENUS Study
por: Mimura, Wataru, et al.
Publicado: (2023)

Multiregional Population-Based Cohort Study for Evaluation of the Association Between Herpes Zoster and mRNA Vaccinations for Severe Acute Respiratory Syndrome Coronavirus-2: The VENUS Study
por: Ishiguro, Chieko, et al.
Publicado: (2023)

Effect of COVID-19 Vaccination on Household Transmission of SARS-CoV-2 in the Omicron Era: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study
por: Maeda, Megumi, et al.
Publicado: (2023)

Development of a COVID-19 vaccine effectiveness and safety assessment system in Japan: The VENUS study
por: Fukuda, Haruhisa, et al.
Publicado: (2023)

Association between seasonal influenza vaccination and antimicrobial use in Japan from the 2015–16 to 2020–21 seasons: from the VENUS study
por: Tsuzuki, Shinya, et al.
Publicado: (2023)

Acute and delayed psychiatric sequelae among patients hospitalised with COVID-19: a cohort study using LIFE study data
por: Murata, Fumiko, et al.
Publicado: (2022)

Anti-Dementia Drug Persistence Following Donepezil Initiation Among Alzheimer’s Disease Patients in Japan: LIFE Study
por: Fukuda, Haruhisa, et al.
Publicado: (2022)

Medical Care and Long-Term Care Expenditures Attributable to Alzheimer’s Disease Onset: Results from the LIFE Study
por: Fukuda, Haruhisa, et al.
Publicado: (2021)

Disease Burden and Progression in Patients with New-Onset Mild Cognitive Impairment and Alzheimer’s Disease Identified from Japanese Claims Data: Evidence from the LIFE Study
por: Fukuda, Haruhisa, et al.
Publicado: (2023)

Estimation of Real-World Vaccination Effectiveness of mRNA COVID-19 Vaccines against Delta and Omicron Variants in Japan
por: Kodera, Sachiko, et al.
Publicado: (2022)

Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance
por: Chinnadurai, Rajkumar, et al.
Publicado: (2022)

The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort
por: Sendi, Parham, et al.
Publicado: (2022)

SARS-CoV-2 Vaccination and Clinical Presentation of COVID-19 in Patients Hospitalized during the Delta- and Omicron-Predominant Periods
por: Stupica, Daša, et al.
Publicado: (2023)

HETEROLOGOUS THIRD AND FOURTH DOSE VACCINE TO REDUCE SEVERITY AND MORTALITY IN COVID-19 PATIENTS DURING DELTA AND OMICRON PREDOMINANT IN THAILAND
por: Chariyalertsak, S., et al.
Publicado: (2023)

Comparative analysis of transmission and vaccine effectiveness in Omicron and Delta variant outbreaks in China
por: Li, Kangguo, et al.
Publicado: (2023)

Antimicrobial utilization and antimicrobial resistance in patients with haematological malignancies in Japan: a multi-centre cross-sectional study
por: Mimura, Wataru, et al.
Publicado: (2020)

Preserved recognition of Omicron spike following COVID-19 messenger RNA vaccination in pregnancy
por: Bartsch, Yannic C., et al.
Publicado: (2022)

Vaccine Effect on Household Transmission of Omicron and Delta SARS-CoV-2 Variants
por: Kim, Yong Chan, et al.
Publicado: (2022)

Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants
por: Niyomnaitham, Suvimol, et al.
Publicado: (2023)

Omicron infection enhances Delta antibody immunity in vaccinated persons
por: Khan, Khadija, et al.
Publicado: (2022)

Estimated Effectiveness of Postpartum Maternal Messenger RNA COVID-19 Vaccination Against Delta and Omicron SARS-CoV-2 Infection and Hospitalization in Infants Younger Than 6 Months
por: Jorgensen, Sarah C. J., et al.
Publicado: (2023)

Framing vaccine mandates: messenger and message effects
por: Buccafusco, Christopher, et al.
Publicado: (2022)

Monovalent Omicron COVID-19 vaccine triggers superior neutralizing antibody responses against Omicron subvariants than Delta and Omicron bivalent vaccine
por: Li, Wanting, et al.
Publicado: (2023)

Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States
por: Schrag, Stephanie J., et al.
Publicado: (2022)

Updated report of COVID-19 vaccine safety monitoring in Japan: booster doses for Omicron variants and vaccinations for infants and young children
por: Yamaguchi, Toshihiro, et al.
Publicado: (2023)

Reduction in severity and mortality in COVID-19 patients owing to heterologous third and fourth-dose vaccines during the periods of delta and omicron predominance in Thailand
por: Intawong, Kannikar, et al.
Publicado: (2023)

SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance
por: Filippatos, Filippos, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Replacement of Delta as Predominant Variant, Puerto Rico
por: Santiago, Gilberto A., et al.
Publicado: (2023)

Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland
por: Norddahl, Gudmundur L., et al.
Publicado: (2022)

Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes
por: Buchan, Sarah A., et al.
Publicado: (2022)

Continued effectiveness of COVID-19 vaccination among urban healthcare workers during delta variant predominance
por: Lan, Fan-Yun, et al.
Publicado: (2022)

Modeling the Impact of Vaccination on COVID-19 and Its Delta and Omicron Variants
por: Wang, Jianbo, et al.
Publicado: (2022)

Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron’s outbreak
por: Ren, Zhenxiao, et al.
Publicado: (2022)

Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave
por: Yamamoto, Shohei, et al.
Publicado: (2023)

The Longevity Improvement & Fair Evidence (LIFE) Study: Overview of the Study Design and Baseline Participant Profile
por: Fukuda, Haruhisa, et al.
Publicado: (2023)

Waning vaccine response to severe COVID-19 outcomes during omicron predominance in Thailand
por: Intawong, Kannikar, et al.
Publicado: (2023)

Effect of COVID-19 Vaccination on the In-Hospital Prognosis of Patients Admitted during Delta and Omicron Waves in Italy
por: Cianci, Rossella, et al.
Publicado: (2023)

Risk of hospitalization and vaccine effectiveness among COVID-19 patients in the UAE during the Delta and Omicron outbreaks
por: Albreiki, Mohammed, et al.
Publicado: (2023)

Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
por: Yamamoto, Shohei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5ucsfq8q4ipqq53oc768nq1lca